4507 On Other Exchanges
Symbol
Exchange
4507 is not on other exchanges.

Executive Profile*

Isao Teshirogi Ph.D.

Chief Executive Officer, President, Representative Director, Member of Compensation Advisory Committee and Member of Nomination Advisory Committee,Shionogi & Co., Ltd.
AgeTotal Calculated CompensationThis person is connected to 45 board members in 3 different organizations across 2 different industries.

See Board Relationships
57¥148,000,000
As of Fiscal Year 2016

Background*

Dr. Isao Teshirogi, Ph.D., has been the President and Chief Executive Officer of Shionogi & Co. Ltd. since April 1, 2008. Dr. Teshirogi served as the Executive General Manager of Pharmaceutical Research & Development Division at Shionogi & Co. Ltd., since 2006 and also served as its General Manager of Pharmaceutical Research & Development Division since 1999, General Manager of Secretary Office from January 1998 to October 2002, General Manager of Corporate Planning ...

Read Full Background

Corporate Headquarters*

1-8, Doshomachi 3-chome
Osaka, -- 541-0045

Japan

Phone: 81 6 6202 2161
Fax: 81 6 6229 9596

Board Members Memberships*

Director
2002-Present
Chief Executive Officer, President, Representative Director, Member of Compensation Advisory Committee and Member of Nomination Advisory Committee
2003-Present
Director

Education*

PhD
The University of Tokyo
BS
The University of Tokyo

Other Affiliations*

Annual Compensation*

Salary¥84,000,000
Bonus¥45,000,000
Total Annual Compensation¥129,000,000

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation¥129,000,000
Total Short Term Compensation¥129,000,000
Total Calculated Compensation¥148,000,000
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Aguiar Chief Executive Officer, President and Director
Innoviva, Inc.
$721.4K
Ian C. Read Chairman and Chief Executive Officer
Pfizer Inc.
$1.9M
Miles D. White Chairman of The Board, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SHIONOGI & CO LTD, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.